You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys Everolimus IVD Elecsys® Everolimus CPS_000467 06633188190 Everolimus Elecsys cobas e 100 Elecsys Everolimus 04015630934089 Reagents, kits 100 tests cobas e 411/601/602 true 07027257190 Everolimus Elecsys E2G 100 Elecsys Everolimus 04015630940349 Reagents, kits 100 tests cobas e 402/801 false 06633188500 Elecsys Everolimus en 4 FF0000000506CF0E FF000000014A640E 06633188190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of everolimus in human whole blood. The assay is used as an aid in the management of kidney, liver and heart transplant patients receiving everolimus therapy.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027257500 Elecsys Everolimus en 4 FF0000000499CE0E FF000000042FB00E 07027257190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of everolimus in human whole blood. The assay is used as an aid in the management of kidney, liver and heart transplant patients receiving everolimus therapy.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027257500 Elecsys Everolimus en 1 FF00000001A3D60E FF00000001A3D60E 07027257190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of everolimus in human whole blood. The assay is used as an aid in the management of kidney, liver and heart transplant patients receiving everolimus therapy.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en
